首页> 美国卫生研究院文献>Oncotarget >Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry
【2h】

Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry

机译:解吸电喷雾电离成像质谱法发现与透明细胞肾细胞癌疾病进展相关的脂质生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clear cell renal cell carcinoma (ccRCC) often results in recurrence or metastasis, and there are only a few clinically effective biomarkers for early diagnosis and personalized therapy. Metabolic changes have been widely studied using mass spectrometry (MS) of tissue lysates to identify novel biomarkers. Our objective was to identify lipid biomarkers that can predict disease progression in ccRCC by a tissue-based approach. We retrospectively investigated lipid molecules in cancerous tissues and normal renal cortex tissues obtained from patients with ccRCC (n = 47) using desorption electrospray ionization imaging mass spectrometry (DESI-IMS). We selected eight candidate lipid biomarkers showing higher signal intensity in cancerous than in normal tissues, with a clear distinction of the tissue type based on the images. Of these candidates, low maximum intensity ratio (cancerousormal) values of ions of oleic acid, m/z 389.2, and 391.3 significantly correlated with shorter progression-free survival compared with high maximum intensity ratio values (P = 0.011, P = 0.022, and P < 0.001, respectively). This study identified novel lipid molecules contributing to the prediction of disease progression in ccRCC using DESI-IMS. Our findings on lipid storage may provide a new diagnostic or therapeutic strategy for targeting cancer cell metabolism.
机译:透明细胞肾细胞癌(ccRCC)通常会导致复发或转移,并且仅有少数临床有效的生物标志物可用于早期诊断和个性化治疗。使用组织裂解物的质谱(MS)来鉴定新的生物标志物已广泛研究了代谢变化。我们的目标是通过基于组织的方法,鉴定可以预测ccRCC疾病进展的脂质生物标志物。我们回顾性研究了使用解吸电喷雾电离成像质谱(DESI-IMS)从ccRCC患者(n = 47)获得的癌组织和正常肾皮质组织中的脂质分子。我们选择了八个候选脂质生物标记物,它们在癌组织中显示出比正常组织更高的信号强度,并根据图像对组织类型进行了明显区分。在这些候选物中,低油酸离子的最大强度比(癌性/正常)值(m / z 389.2和391.3)与较高的最大强度比值相比具有较短的无进展生存率(P = 0.011,P = 0.022) ,分别为P <0.001)。这项研究使用DESI-IMS确定了有助于预测ccRCC疾病进展的新型脂质分子。我们关于脂质存储的发现可能为靶向癌细胞代谢提供新的诊断或治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号